I own it.
We solve it.
We love it.
for each patient, our
customers, and team.
Together, we will make HeartFlow the primary diagnostic and treatment planning tool for all patients with coronary artery disease.
Redwood City, California
London, United Kingdom
Founded HeartFlow in Silicon Valley, California
Awarded CE Mark
Received U.S. FDA de novo 510(k) clearance
Commercially available in the U.S., Canada, Europe and Japan
Launched ADVANCE Registry to evaluate data from 5,000 patients
NICE Guidance recommends HeartFlow
> 10,000 patients worldwide have received the HeartFlow Analysis
Announced collaboration with Siemens Healthineers